Cerebral Autoregulation and COVID-19 (CA-COVID)
Cerebral Autoregulation and Severe Coronavirus Disease 19 [CA-COVID]: a Single-center Physiological Study
Sponsor: University of Athens
Terminated
Low rate of enrollment
Other terminated trials from University of Athens
Other COVID-19 Acute Respiratory Distress Syndrome trials with similar outcome
Browse all COVID-19 Acute Respiratory Distress Syndrome trials
Listed as NCT04930874, this NA trial focuses on COVID-19 Acute Respiratory Distress Syndrome and COVID-19 Pneumonia and remains terminated or withdrawn. Sponsored by University of Athens, it has been updated 8 times since 2021, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
8 versions recorded-
Jan 2025 — Present [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Sep 2024 — Jan 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Dec 2023 — Jul 2024 [monthly]
Recruiting NA
-
Jun 2023 — Dec 2023 [monthly]
Recruiting NA
▶ Show 3 earlier versions
-
Jan 2022 — Jun 2023 [monthly]
Recruiting NA
-
Oct 2021 — Jan 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2021 — Oct 2021 [monthly]
Not Yet Recruiting NA
First recorded
Jun 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Athens
For direct contact, visit the study record on ClinicalTrials.gov .